IRIS
Demichelis, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.531
EU - Europa 1.751
AS - Asia 1.124
SA - Sud America 57
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
Totale 13.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.503
SG - Singapore 547
IT - Italia 376
CN - Cina 336
SE - Svezia 296
UA - Ucraina 257
FI - Finlandia 232
GB - Regno Unito 217
DE - Germania 156
VN - Vietnam 77
BG - Bulgaria 58
RU - Federazione Russa 58
ID - Indonesia 53
BR - Brasile 49
JO - Giordania 26
CA - Canada 25
LU - Lussemburgo 22
IN - India 18
TR - Turchia 17
HK - Hong Kong 16
AT - Austria 11
CZ - Repubblica Ceca 8
NL - Olanda 8
BE - Belgio 7
AU - Australia 6
CL - Cile 5
ES - Italia 5
IR - Iran 5
JP - Giappone 5
LT - Lituania 5
NO - Norvegia 5
RO - Romania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
FR - Francia 4
KR - Corea 4
PL - Polonia 4
EU - Europa 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AZ - Azerbaigian 2
CH - Svizzera 2
EE - Estonia 2
IE - Irlanda 2
IL - Israele 2
IQ - Iraq 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MC - Monaco 1
ME - Montenegro 1
MK - Macedonia 1
MX - Messico 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 13.485
Salva come PNG Salva come JPEG
Città #
Fairfield 1.720
Chandler 956
Ashburn 836
Woodbridge 790
Seattle 695
Houston 623
Jacksonville 610
Cambridge 586
Wilmington 558
Singapore 419
San Mateo 334
Ann Arbor 326
Santa Clara 322
Columbus 292
Princeton 226
Beijing 124
Trento 120
Helsinki 119
San Diego 108
New York 90
Boardman 82
Dearborn 79
London 76
Lawrence 70
Los Angeles 61
Sofia 58
Como 56
Jakarta 53
Dong Ket 50
Moscow 46
Munich 43
Falls Church 40
Bremen 34
Norwalk 27
San Paolo di Civitate 27
Tolentino 23
Hesperange 22
Altamura 21
Des Moines 21
Toronto 21
Bend 20
Dallas 20
Washington 17
Kilburn 16
Düsseldorf 15
Izmir 15
Hong Kong 14
Andover 13
Hefei 12
Kunming 11
Rome 11
Bonndorf 10
Chiswick 9
Nanjing 9
Phoenix 9
Acton 8
Bassano del Grappa 8
New Bedfont 8
Nuremberg 8
Riva Del Garda 8
Vienna 8
Wandsworth 8
Brno 7
Brussels 7
Frankfurt am Main 7
Shanghai 7
Zhengzhou 7
Chicago 6
Civitanova Marche 6
Lappeenranta 6
Milan 6
Prescot 6
São Paulo 6
Bolzano 5
Dormagen 5
Guangzhou 5
Pune 5
Tappahannock 5
Chongqing 4
Daiano 4
Hounslow 4
Laurel 4
Lavis 4
Mountain View 4
Oslo 4
Ottawa 4
Padova 4
Redmond 4
Southwark 4
Vicenza 4
Auckland 3
Belo Horizonte 3
Berlin 3
Bovolone 3
Chengdu 3
Fuzhou 3
Hebei 3
Newark 3
San Michele All'adige 3
Tokai 3
Totale 11.195
Salva come PNG Salva come JPEG
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 264
Inherited determinants of early recurrent somatic mutations in prostate cancer 252
EthSEQ: ethnicity annotation from whole exome sequencing data 193
A highly specific SpCas9 variant is identified by in vivo screening in yeast 182
ASEQ: Fast allele-specific studies from next-generation sequencing data 160
Patient derived organoids to model rare prostate cancer phenotypes 154
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes. 151
Personalized in vitro and in vivo cancer models to guide precision medicine 151
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 148
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 143
Genomic correlates of clinical outcome in advanced prostate cancer 141
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 138
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. 135
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer 132
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients 128
TPES: Tumor Purity Estimation from SNVs 122
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 121
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 120
The landscape of somatic copy-number alteration across human cancers. 120
EML4-ALK fusion lung cancer: a rare acquired event. 120
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 120
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 117
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 117
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 116
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model 115
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer 113
In-silico identification and functional validation of allele-dependent AR enhancers 112
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 108
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. 107
Ancestry-specific predisposing germline variants in cancer 107
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 107
The Molecular Taxonomy of Primary Prostate Cancer 106
Variants at IRX4 as prostate cancer expression quantitative trait loci. 105
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. 105
Testing mutual exclusivity of ETS rearranged prostate cancer. 105
An automated procedure to properly handle digital images in large scale tissue microarray experiments. 104
Role of non-coding sequence variants in cancer 103
A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. 103
Punctuated evolution of prostate cancer genomes. 102
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. 102
Clonal evolution of chemotherapy-resistant urothelial carcinoma 102
Tumor clone dynamics in lethal prostate cancer 101
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 101
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 101
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. 100
A step toward functionally characterized prostate cancer molecular subtypes. 99
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 99
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. 98
The virtual case: a new method to completely digitize cytological and histological slides. 98
Oncogene-mediated alterations in chromatin conformation 98
Plasma AR and abiraterone-resistant prostate cancer 98
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. 97
The genomic complexity of primary human prostate cancer. 97
Robotic telepathology for intraoperative remote diagnosis using a still-imaging-based system. 97
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 96
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. 96
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. 96
User attitudes in analyzing digital slides in a quality control test bed: a preliminary study. 96
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. 96
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease 95
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment 95
Genetic predisposition to prostate cancer: Update and future perspectives 95
A computational framework discovers new copy number variants with functional importance. 95
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. 94
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer 94
TMABoost: an integrated system for comprehensive management of tissue microarray data. 93
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. 92
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. 92
Integrative clinical genomics of advanced prostate cancer 92
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. 91
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. 91
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. 91
Digital Pathology: Science Fiction? 91
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. 91
Large oncosomes mediate intercellular transfer of functional microRNA. 90
Recurrent gene fusions in prostate cancer 90
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. 90
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 90
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. 89
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression 89
Design and initial implementation of a regional tele-oncology project. 88
ERG rearrangement metastasis patterns in locally advanced prostate cancer. 88
Unraveling the clonal hierarchy of somatic genomic aberrations 88
Antibody-based detection of ERG rearrangement-positive prostate cancer. 87
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. 87
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines. 87
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets 86
Digital storage of glass slides for quality assurance in histopathology and cytopathology. 86
Molecular genetics of prostate cancer: Emerging appreciation of genetic complexity 86
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. 86
The lethal clone in prostate cancer: redefining the index 85
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation 84
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk 84
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer 83
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. 83
Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomes. 82
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. 82
ABEMUS: platform specific and data informed detection of somatic SNVs in cfDNA 82
V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application. 81
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. 81
Totale 10.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 521
selected - selezionate 0
volume - volumi 263
Totale 69.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.568 0 0 0 0 0 0 339 280 432 249 108 160
2020/20212.590 40 357 159 330 265 182 151 162 161 230 282 271
2021/20222.157 249 327 14 92 36 81 83 390 137 212 181 355
2022/20232.024 267 235 13 328 210 316 30 145 252 34 122 72
2023/2024822 49 77 67 28 76 177 45 92 10 80 32 89
2024/20251.702 18 36 235 669 246 461 37 0 0 0 0 0
Totale 13.783